In the tumor of patient #1, we detected mutations in tumor suppressor genes such as MYO18B and CTNN2 and in genes related to adhesion, invasiveness, and survival (e.g., CDH23, HMCN1, and OBSCN) in samples collected at the resistance that were not present initially (Supplementary Data 1). The gene discussed is OBSCN; the disease is neoplasm.